Autologous platelet concentrates for treating periodontal infrabony defects.
Massimo Del Fabbro,Lorena Karanxha,Saurav Panda,Cristina Bucchi,Jayakumar Nadathur Doraiswamy,Malaiappan Sankari,Surendar Ramamoorthi,Sheeja Varghese,Silvio Taschieri
DOI: https://doi.org/10.1002/14651858.CD011423.pub2
IF: 8.4
2019-10-04
Cochrane Database of Systematic Reviews
Abstract:Periodontal disease is a condition affecting tooth-supporting tissues (gingiva, alveolar bone, periodontal ligament, and cementum), with the potential of introducing severe adverse effects on oral health. It has a complex pathogenesis which involves the combination of specific micro-organisms and a predisposing host response. Infrabony defects are one of the morphological types of alveolar bone defects that can be observed during periodontitis. Recent approaches for the treatment of infrabony defects, combine advanced surgical techniques with platelet-derived growth factors. These are naturally synthesized polypeptides, acting as mediators for various cellular activities during wound healing. It is believed that the adjunctive use of autologous platelet concentrates to periodontal surgical procedures produces a better and more predictable outcome for the treatment of infrabony defects.
medicine, general & internal